Brief: Catalent Says Ardena Signs Agreement To Expand US Footprint With Acquisition Advanced Drug Product Manufacturing Facility From Co
14/10/2024 11:45
Oct 14 (Reuters) - Catalent Inc CTLT.N :
* ARDENA SIGNS AGREEMENT TO EXPAND US FOOTPRINT WITH THE
ACQUISITION OF ADVANCED DRUG PRODUCT MANUFACTURING FACILITY FROM
CATALENT
Source text for Eikon: ID:nGNX3mzBBS
Further company coverage: CTLT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Catalent
See all newsBrief: Novo Holdings Completes Acquisition Of Catalent
Novo Nordisk rises as Catalent deal in US nears
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
Brief: Catalent And Novo Holdings Fulfill All Regulatory Closing Conditions For Pending Transaction
Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled